The debates around DTx often focus on its value to pharma, its viability as an industry, and the slowdown in recent years.\r\nThese debates have their place, but surely they miss the point? DTx is, first and foremost, for patients. To improve the lives of those receiving treatment. To enhance, empower, and invigorate the traditional treatment pathway with new powers and purpose.\r\nJoin patients to learn first hand their experiences of various DTx applications. From prescription to download, the highs, lows and potential progress plateaus. The breakthroughs, and the breakdowns. Because when it comes to DTx, the debates can rage on all they like. What matters most are the patients.